Source: Annual Congress 2007 - Treatment of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Skrahin, A. Astrauko, H. Hurevich, A. Skrahina (Minsk, Belarus). Methionine in COPD treatment. Eur Respir J 2007; 30: Suppl. 51, 594

Member's Comments

No comment yet.

Related content which might interest you: N-acetylcysteine for the treatment of acute exacerbations of COPD Source: Eur Respir J 2002; 20: Suppl. 38, 374s Year: 2002 Exacerbations of COPD and treatment Source: International Congress 2018 – PG1 Asthma and chronic obstructive pulmonary disease Year: 2018 Pharmacologic treatment of exacerbations of COPD Source: International Congress 2016 – Management of COPD exacerbations: A European Respiratory Society/American Thoracic Society (ERS/ATS) guideline Year: 2016 Compliance of COPD patients to their treatment Source: Eur Respir J 2003; 22: Suppl. 45, 244s Year: 2003 Methylated arginine derivatives can differ stable and unstable patients with COPD Source: Annual Congress 2013 –Biomarkers in asthma and COPD Year: 2013 CAT predicts mortality in COPD patients who require LTOT Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Treatment programs in COPD Source: Virtual Congress 2020 – Russian speaking programme 2020: Part II Year: 2020 Phenotype-based therapy of COPD: Effect on the rate of COPD exacerbations Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 High-dose N-acetylcysteine in the prevention of COPD exacerbations: Results of the PANTHEON study Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs Year: 2013 Changes in inhalation therapy after combined assessment of COPD Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 Treatment of infection in COPD exacerbations Source: International Congress 2014 – PG16 Low respiratory tract infections: learning from real clinical cases Year: 2014 Screening of inhalation technique and treatment adherence of COPD, asthma and ACO patients Source: International Congress 2019 – Inhalers: adherence and preference Year: 2019 Roflumilast added to triple therapy in severe COPD patients with frequent exacerbations: Efficacy and tolerability Source: International Congress 2014 – Markers Year: 2014 Estimation of tiotropium efficacy at the COPD patients with group D Source: International Congress 2015 – Different data in COPD Year: 2015 Effect of exacerbation history and ICS use on outcomes in COPD patients from the TIOSPIR™ trial Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Recommendations for pharmacological treatment of exacerbations of COPD Source: International Congress 2017 – Treatment and prevention of COPD exacerbation Year: 2017 Efficacy of roflumilast with concomitant cardiovascular medication in patients with COPD Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management Year: 2013 Screening eosinophil counts and risk of exacerbations after inhaled corticosteroid withdrawal in severe COPD Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Lung function and treatment patterns of symptomatic patients with moderate COPD in the CRYSTAL study Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016